Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting
Study Identifier
P15-769
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting. The objectives of this study are to estimate the effectiveness of adalimumab treatment on disease severity, to estimate the impact of adalimumab treatment on patients' quality of life, psychological effect, work productivity and healthcare resource utilization and to describe treatment practices over the study period.
Study Locations
Location
Status
Location
Krankenanstalt Rudolfstiftung /ID# 166804
Vienna, State of Vienna, Austria, 1030
Status
Not applicable
Location
LKH-Univ. Klinikum Graz /ID# 166802
Graz, Austria, 8036
Status
Not applicable
Location
Klinikum Wels - Grieskirchen /ID# 158017
Wels, Austria, 4600
Status
Not applicable
Location
UZ Brussel /ID# 154218
Jette, Brussels Capital, Belgium, 1090
Status
Not applicable
Location
Cliniques Universitaires Saint Luc /ID# 154217
Woluwe-Saint-Lambert, Brussels Capital, Belgium, 1200
Status
Not applicable
Location
CHU de Liege /ID# 154220
Liège, Liege, Belgium, 4000
Status
Not applicable
Showing {first} - {last} of {total} Results